摘要
血府逐瘀胶囊(Xuefu Zhuyu Capsule,XZC)是一种传统中药制剂,具有活血化瘀、舒筋活络的作用。在临床实践中被广泛用于治疗瘀血相关疾病。此外XZC还具有一定的抗炎和抗氧化活性。通过对近年来XZC中所含化学成分及其药理作用进行总结,基于中药质量标志物(quality marker,Q-Marker)核心理论,应用网络药理学方法分析预测XZC的Q-Marker。结果表明芍药苷、阿魏酸、甘草苷、甘草酸、苦杏仁苷可作为XZC的Q-Marker,为XZC的后续研究提供质量控制参考。
Xuefu Zhuyu Capsule(血府逐瘀胶囊,XZC)is a traditional Chinese medicine(TCM)preparation that has the effects of promoting blood circulation,removing blood stasis,and relaxing tendons and activating collaterals.It is widely used in clinical practice to treat blood stasis related diseases.In addition,XZC also has certain anti-inflammatory and antioxidant activities.By summarizing the chemical components and pharmacological effects of XZC in recent years,based on the core theory of TCM quality marker(Q-Marker),network pharmacology methods are applied to analyze and predict the Q-Marker of XZC.The results indicated that paeoniflorin,ferulic acid,liquiritin,glycyrrhizic acid,and amygdalin can serve as Q-Marker for XZC,providing quality control references for subsequent research on XZC.
作者
贺木兰
王玺
何成峙
余河水
宋纹
张营
王跃飞
李正
李文龙
HE Mulan;WANG Xi;HE Chengzhi;YU Heshui;SONG Wen;ZHANG Ying;WANG Yuefei;LI Zheng;LI Wenlong(College of Pharmaceutical Engineering of Traditional Chinese Medicine,Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China;Haihe Laboratory of Modern Chinese Medicine,Tianjin 301617,China;Tianjin HongRenTang Pharmaceutical Co.,Ltd.,Tianjin 300380,China)
出处
《中草药》
CAS
CSCD
北大核心
2024年第11期3886-3897,共12页
Chinese Traditional and Herbal Drugs
基金
国家重点研发计划资助项目(2023YFC3504502)
现代中医药海河实验室-天津宏仁堂药业有限公司合作项目(XMH2022004)
现代中医药海河实验室科技计划资助项目(22HHZYSS00004)。
关键词
血府逐瘀胶囊
网络药理学
质量标志物
芍药苷
阿魏酸
甘草苷
甘草酸
苦杏仁苷
Xuefu Zhuyu Capsule
network pharmacology
quality markers
paeoniflorin
ferulic acid
liquiritin
glycyrrhizic acid
amygdalin